Peripheral Neuritis Treatment Market Report 2026

Peripheral Neuritis Treatment Market Overview

• Peripheral Neuritis Treatment market size has reached to $1.93 billion in 2025 • Expected to grow to $2.44 billion in 2030 at a compound annual growth rate (CAGR) of 4.8% • Growth Driver: Impact Of Rising Diabetes Prevalence On The Growth Of The Market • Market Trend: Advancements In Peripheral Neuritis Treatment Magnetic Peripheral Nerve Stimulation (Mpns) For Pain Relief And Nerve Regeneration • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Peripheral Neuritis Treatment Market?

Peripheral neuritis refers to the inflammation or damage of peripheral nerves, leading to symptoms such as pain, weakness, numbness, and tingling, often caused by diabetes, infections, toxins, or nutritional deficiencies, with treatment involving medications, physical therapy, lifestyle modifications, and management of underlying conditions. The main treatment types of peripheral neuritis treatment are pharmacological and non-pharmacological therapies. Pharmacological therapies involve the use of medications such as pain relievers, anticonvulsants, and antidepressants to manage peripheral neuritis by reducing pain signals and improving nerve function. These drugs are classified into antidepressants, anticonvulsants, local anesthetics, analgesics, steroids, and other drug classes. They are distributed through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and drug stores. These are used for various applications such as diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, idiopathic peripheral neuropathy, and others.

What Is The Peripheral Neuritis Treatment Market Growth Forecast?

The peripheral neuritis treatment market size is expected to see steady growth in the next few years. It will grow to $2.44 billion in 2030 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to advancements in pharmacological therapies, increasing adoption of non-pharmacological therapies such as tens and acupuncture, rising use of online and retail pharmacies, growing focus on lifestyle and dietary modifications, expansion of diabetic care programs and specialized clinics. Major trends in the forecast period include increasing adoption of ai-based peripheral neuritis monitoring tools, rising integration of digital health platforms for peripheral neuropathy management, growing use of genomic and precision medicine approaches in peripheral neuritis, increasing implementation of iot-enabled patient monitoring devices, rising development of smart manufacturing for peripheral neuritis therapeutics.

Global Peripheral Neuritis Treatment Market Segmentation

1) By Treatment Type: Pharmacological Therapies, Non Pharmacological Therapies 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores 3) By Application: Diabetic Peripheral Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, Other Applications Subsegments: 1) By Pharmacological Therapies: Pain Relievers (Analgesics), Antidepressants, Anticonvulsants, Topical Medications 2) By Non-Pharmacological Therapies: Physical Therapy, Transcutaneous Electrical Nerve Stimulation (TENS), Acupuncture, Lifestyle And Dietary Modifications

What Is The Driver Of The Peripheral Neuritis Treatment Market?

The rising prevalence of diabetes is expected to propel the growth of the peripheral neuritis treatment market going forward. Diabetes is a chronic medical condition that occurs when the body is unable to properly regulate blood sugar (glucose) levels. The rising prevalence of diabetes is due to factors such as sedentary lifestyles, unhealthy diets, obesity, aging populations, and genetic predisposition. Peripheral neuritis treatment supports diabetic individuals by relieving nerve pain, reducing inflammation, and enhancing nerve function, helping to improve their quality of life and prevent complications. For instance, in 2024, according to the International Diabetes Federation, a Belgium-based diabetes research organization, published that the number of adults aged 20 to 79 years living with diabetes worldwide is projected to increase significantly from about 589 million in 2024 to 853 million by 2050, representing a 45% increase. Therefore, the rising prevalence of diabetes is driving the growth of the peripheral neuritis treatment industry.

Key Players In The Global Peripheral Neuritis Treatment Market

Major companies operating in the peripheral neuritis treatment market are Pfizer Inc., Johnson & Johnson (J&J), AstraZeneca Plc, Novartis AG, GSK plc, Takeda Pharmaceuticals & Co. Ltd., Eli Lilly and Co., Mallinckrodt Pharmaceuticals plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Apotex Inc., Dr Reddys Laboratories Ltd., Cipla Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Daiichi Sankyo Co. Ltd., Glenmark Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd.

Global Peripheral Neuritis Treatment Market Trends and Insights

Major companies in the peripheral neuritis treatment market are focusing on the development of innovative treatments such as magnetic peripheral nerve stimulation (mPNS) treatment to enhance nerve regeneration and reduce neuropathic pain. Magnetic peripheral nerve stimulation (mPNS) treatment refers to a non-invasive neuromodulation technique that uses magnetic fields to stimulate peripheral nerves, helping to manage pain, enhance nerve regeneration, and improve motor function in conditions such as neuropathy and musculoskeletal disorders. For instance, in January 2024, Neuralace Medical Inc., a US-based medical equipment manufacturing company, announced Axon Therapy (mPNS), for the treatment of chronic painful diabetic neuropathy (PDN), approved by the Food and Drug Administration, a US-based government agency. This therapy provides a quick, painless, and noninvasive approach to pain relief. Clinical trials demonstrated a 72.3% responder rate at Day 30 and an 81.4% responder rate at Day 90, highlighting its effectiveness in reducing pain and numbness. This approval marks a significant advancement in pain management, offering patients an alternative to traditional treatments without the side effects of medication.

What Are Latest Mergers And Acquisitions In The Peripheral Neuritis Treatment Market?

In October 2024, Alkem Laboratories Limited, an India-based pharmaceutical company, partnered with Sonnet BioTherapeutics. The collaboration between Alkem Laboratories and Sonnet BioTherapeutics aims to develop, manufacture, and commercialize Sonnet's drug candidate SON-080 for the treatment of diabetic peripheral neuropathy (DPN) in India. Sonnet BioTherapeutics is a US-based biotechnology company that focuses on oncology.

Regional Outlook

North America was the largest region in the peripheral neuritis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Peripheral Neuritis Treatment Market?

The peripheral neuritis treatment market consists of revenues earned by entities by providing services such as pharmacological treatment, physical therapy and rehabilitation, nutritional and dietary support, lifestyle management and patient education. The market value includes the value of related goods sold by the service provider or included within the service offering. The peripheral neuritis treatment market also includes sales of pain relievers, antidepressants, anticonvulsants, and corticosteroids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Peripheral Neuritis Treatment Market Report 2026?

The peripheral neuritis treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral neuritis treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.